Eupraxia Pharmaceuticals Inc. Free Cash Flow for the year ending December 31, 2024: USD -30.10 M

Eupraxia Pharmaceuticals Inc. Free Cash Flow is USD -30.10 M for the year ending December 31, 2024, a 42.39% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Eupraxia Pharmaceuticals Inc. Free Cash Flow for the year ending December 31, 2023 was USD -21.14 M, a 50.14% change year over year.
  • Eupraxia Pharmaceuticals Inc. Free Cash Flow for the year ending December 31, 2022 was USD -14.08 M, a 18.14% change year over year.
  • Eupraxia Pharmaceuticals Inc. Free Cash Flow for the year ending December 31, 2021 was USD -11.92 M.
Key Data
Date Free Cash Flow Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities